Repository logo
 
Publication

Evaluation of the potential of marine cyanobacteria towards Alzheimer’s disease

dc.contributor.authorMoreira, Ana Rita
dc.contributor.authorSilva, Ana Margarida
dc.contributor.authorVieira, Mónica
dc.contributor.authorMartins, Rosário
dc.date.accessioned2024-06-07T08:41:01Z
dc.date.available2024-06-07T08:41:01Z
dc.date.issued2022-10-21
dc.description.abstractAlzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases (NDs) and the major cause of dementia. Despite the constant efforts to achieve cure, no treatment is currently effective and new approaches are urgently needed. Marine biotechnology has been at the frontline for the bioprospection of natural sources to treat ND. Several marine compounds have already provided evidence for anti-AD drugs by acting in mechanisms such as the inhibition of acetylcholinesterase (AChE). Among marine organisms, cyanobacteria have been recognized as a major source of bioactive compounds and the potential towards AD has been highlighted, namely AChE inhibitors. This project is included in a screening program that aims to evaluate the potential of cyanobacteria from the Culture Collection of CIIMAR -LEGE-CC against AD. In this work, 80 fractions of marine cyanobacteria were screened for the potential to inhibit AChE since this is a proven enzyme target to ameliorate the loss of cholinergic signal and to induce cytotoxicity in the neuroblastoma cell line SHY5Y, in the normal fibroblasts cell line 3T3L1, and in the endothelial cells from central nervous system capillaries hCMEC/D3. Results considering the enzymatic assays and cytotoxic assays revealed that the fractions are not toxic or with low toxicity. The strains Phormidium sp; an unidentified filamentous Synechococcales and Nodosilinea nodulosa revealed moderate toxicity towards AChE.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationMoreira, A. R., Silva, A. M., Vieira, M., & Martins, R. (2022). Evaluation of the potential of marine cyanobacteria towards Alzheimer’s disease. Book of Abstracts of 5th Meeting of Medicinal Biotechnology (5MBtM) and 2nd Iberian Congress on Medicinal Biotechnology, 37. https://paginas.ess.ipp.pt/ebtm/2022/5EBTM_BookOfAbstracts.pdfpt_PT
dc.identifier.urihttp://hdl.handle.net/10400.22/25633
dc.language.isoengpt_PT
dc.publisherEscola Superior de Saúde P.Portopt_PT
dc.relation.publisherversionhttps://paginas.ess.ipp.pt/ebtm/2022/5EBTM_BookOfAbstracts.pdfpt_PT
dc.subjectAlzheimer diseasept_PT
dc.subjectCyanobacteriapt_PT
dc.subjectCytotoxicitypt_PT
dc.subjectAcetylcholinesterasept_PT
dc.titleEvaluation of the potential of marine cyanobacteria towards Alzheimer’s diseasept_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlacePortopt_PT
oaire.citation.startPage37pt_PT
oaire.citation.titleBook of Abstracts of 5th Meeting of Medicinal Biotechnology (5MBtM) and 2nd Iberian Congress on Medicinal Biotechnologypt_PT
person.familyNameSilva
person.familyNameAlmeida Vieira
person.familyNameMartins
person.givenNameAna Margarida
person.givenNameMónica Andreia
person.givenNameRosario
person.identifier.ciencia-id9712-AF1E-C8D1
person.identifier.ciencia-idA01E-9178-9B48
person.identifier.ciencia-idA919-DB40-EF10
person.identifier.orcid0000-0002-9582-3178
person.identifier.orcid0000-0002-8687-4811
person.identifier.orcid0000-0002-9882-4651
person.identifier.scopus-author-id21834368700
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isAuthorOfPublication76fafad5-3c94-44d5-bc2a-9814e0ecb940
relation.isAuthorOfPublication861e9c68-4ecc-4be1-a794-852343368e9a
relation.isAuthorOfPublication82a7c349-c88e-450f-adc7-3331d69149cf
relation.isAuthorOfPublication.latestForDiscovery82a7c349-c88e-450f-adc7-3331d69149cf

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
POSTER_Ana Margarida Silva.pdf
Size:
5.14 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: